FindTrial
Sign In

A Simple Saliva Test for Predicting Head and Neck Cancer Outcomes A Pilot Study

Detection of salivary beta hcg using home based pregnancy test kits as a prognostic indicator in patients with head and neck squamous cell carcinoma a pilot study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103839
Enrollment
15
Registered
2026-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

Intervention1: Nil: Nil Intervention2: SINGLE ARM STUDY: For treatment and diagnosis of Head and Neck Cancer patients 10ml of unstimulated saliva is collected in sterile sample container box and A hom

Sponsors

SUBBAIAH INSTITUTE OF DENTAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Suspected patients of OSCC who have not yet undergone biopsy 20 to 65 years Informed consent Patients who have not yet received any form of treatment for OSCC

Exclusion criteria

Exclusion criteria: Other than OSCC Patients previously treated for OSCC Pregnant or lactating women Patients with systemic diseases Patients using hormonal medications

Design outcomes

Primary

MeasureTime frame
evaluate the potential of salivary beta hCG as a non invasive biomarker for prognosis in head and neck cancerTimepoint: At baseline—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr DEEPAKRAJ K C

SUBBAIAH INSTITUTE OF DENTAL SCIENCES NH13 PURLE SHIVAMOGGA

hpvivek_goku@yahoo.com8095306448

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026